药物治疗是否有效治疗失言症?
Guadalupe Dávila1,2,3,4, Marcelo L Berthier1,2,4
1Cognitive Neurology and Aphasia Unit, Centro de Investigaciones Médico-Sanitarias, University of Málaga, Málaga, Spain.
Expert review of neurotherapeutics
|February 7, 2024
概括
目前,对失语症的药物治疗显示出有限的有效性. 需要更多的研究来确定最佳的药物治疗中风或神经退行性疾病引起的沟通障碍.
科学领域:
- 神经学 神经学
- 语音语言病理学 语言病理学
背景情况:
- 失言症是一种使人虚弱的沟通障碍,影响言语,理解,阅读和写作.
- 它通常是由于中风或神经退行性疾病影响左脑半球造成的.
- 有效的治疗策略对于管理失言症对日常生活的影响至关重要.
研究的目的:
- 评估当前药物治疗策略治疗失语症的疗效.
- 探索不同原因的失言症可能如何影响治疗结果.
- 提供专家对当前和未来的药物治疗对失语症的观点.
主要方法:
- 审查和分析现有的药物治疗方法治疗失语症.
- 在治疗疗效方面考虑失语病因 (血管与神经退行性).
- 关于药物治疗当前状况的专家意见综合.
主要成果:
- 目前治疗失语症的药物疗法的有效性仍然没有确定性.
- 需要进一步的研究,重点关注语言和沟通缺陷.
- 生物标志物可以增强阿法西亚患者的个性化治疗计划.
结论:
- 目前的药物治疗没有为失言症提供明确的解决方案.
- 未来的研究应该优先考虑详细的语言评估和生物标志物识别.
- 个性化医疗方法有望改善语障治疗.
相关概念视频
01:22Alzheimer's Disease: Treatment
193
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
193
01:26Psychosis: Goals of Pharmacotherapy
131
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
131
01:28Drug Therapy
44
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
44
01:24Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
675
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
675
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
126
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
126